Possible 'Showstopper' Ruling Looms In GSK Birth Defect Suit
A federal judge said during a Wednesday hearing that a ruling on whether claims that GlaxoSmithKline's anti-nausea medication Zofran triggers birth defects are preempted will be coming soon, a decision he's...To view the full article, register now.
Already a subscriber? Click here to view full article